$195.00
-4.33-2.17%
In chiusura: Nov 20, 4:00 PM EST
$199.30
4.302.21%
Post-mercato: 7:56 PM EST

Moderna (MRNA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 6, 2026 | $0.38 | $-1.22 | 131.2 % |
| Q2 | Jul 31, 2026 | $-1.97 | $-2.07 | 4.83 % |
| Q1 | May 1, 2026 | $-1.18 | $-3.71 | 68.2 % |
| Q4 | Feb 13, 2026 | $-2.11 | $-2.60 | 18.9 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 6, 2026 | $1.31B | $889.93M | 47.5 % |
| Q2 | Jul 31, 2026 | $145.00M | $104.40M | 38.9 % |
| Q1 | May 1, 2026 | $389.00M | $233.79M | 66.4 % |
| Q4 | Feb 13, 2026 | $678.00M | $638.92M | 6.12 % |
Moderna (MRNA) ha pubblicato l'ultima guidance il novembre 12, 2026 per fiscal year 2026. La società ha previsto un fatturato pari a $2.24B - $2.43B per il periodo.
Rispetto alle previsioni precedenti, Moderna ha modificato le sue previsioni di fatturato da un intervallo precedente di .
Moderna ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il Moderna. 15
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.22 | $-2.07 | $-3.71 | $-2.60 |
| Actual | $0.38 | $-1.97 | $-1.18 | $-2.11 |
| Surprise | +131.2% | +4.83% | +68.2% | +18.9% |
| Revenue | ||||
| Estimate | $889.9M | $104.4M | $233.8M | $638.9M |
| Actual | $1.31B | $145.0M | $389.0M | $678.0M |
| Surprise | +47.5% | +38.9% | +66.4% | +6.12% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.19 | $-1.79 | $-2.03 | $0.45 |
| Revenue | ||||
| Consensus | $588.4M | $262.8M | — | — |